TCTR20160911001已完成3 期
Efficacy and safety of bimatoprost 0.01% for the treatment of eyebrow hypotrichosis: A randomized, double-blind, vehicle-controlled study
Division of Dermatology, Ramathibodi Hospital, Mahidol University0 个研究点目标入组 40 人开始时间: 2016年9月11日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.Healthy male and female subject
- •2.Diagnosis of eyebrow hypotrichosis
- •3.Agree to participate and signed informed consent form
排除标准
- •1.History of eyebrow transplant
- •2.Applying topical hair growth products within 2 weeks
- •3.Receiving light and laser treatment of the eyebrow within 3 months
- •4.Taking oral medication influenced hair within 6 months
- •5.History of systemic illness
- •6.Pregnancy or breast feeding
研究者
相似试验
尚未招募
4 期
Research study to evaluate safety and effectiveness of preservative free bimatoprost 0.01% ophthalmic solution in comparison to conventional bimatoprost 0.01%) ophthalmic solution in glaucoma or ocular hypertension patients in Indian populatioCTRI/2019/04/018738Sun Pharma Laboratories Ltd
已完成
4 期
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)Glaucoma, Open-AngleOcular HypertensionNCT01594970Allergan800
进行中（未招募）
不适用
Comparison between the effects on ocular pressure of Bimatoprost 0.01% and Timolol 0.5% during the day and nightglaucoma and ocular hypertensionMedDRA version: 14.1Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersEUCTR2010-024272-26-ITIRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS
进行中（未招募）
1 期
The Efficacy and Safety of Bimatoprost SR in Patients with Open-angle Glaucoma or Ocular HypertensioEUCTR2014-003037-26-HUAllergan Limited600
进行中（未招募）
1 期
The Efficacy and Safety of Bimatoprost SR in Patients with Open-angle Glaucoma or Ocular HypertensioOpen-angle Glaucoma and Ocular HypertensionMedDRA version: 20.0 Level: HLGT Classification code 10018307 Term: Glaucoma and ocular hypertension System Organ Class: 100000004853MedDRA version: 20.0 Level: PT Classification code 10030043 Term: Ocular hypertension System Organ Class: 10015919 - Eye disordersMedDRA version: 20.0 Level: PT Classification code 10030348 Term: Open angle glaucoma System Organ Class: 10015919 - Eye disordersEUCTR2014-003037-26-ATAllergan Limited600